Feb 01, 2012, 07.15 PM IST

Socrus Bio Scie Dec '11 sales at Rs 8.50 crore

Socrus Bio Sciences has reported a sales turnover of Rs 8.50 crore and a net profit of Rs 2.02 crore for the quarter ended Dec '11

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Socrus Bio Sciences has reported a sales turnover of Rs 8.50 crore and a net profit of Rs 2.02 crore for the quarter ended Dec '11.
For the quarter ended Dec 2010 the sales turnover was Rs 6.34 crore and net profit was Rs 0.29 crore.
Quarterly Results of Socrus Bio Sciences-------- in Rs. Cr. --------
Dec '10Sep '11Dec '11
Sales Turnover6.348.278.50
Other Income0.02----
Total Income6.368.278.50
Total Expenses6.066.366.47
Operating Profit0.281.912.03
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit0.301.912.03
Interest------
PBDT0.311.912.04
Depreciation0.020.020.02
Depreciation On Revaluation Of Assets------
PBT0.291.892.02
Tax------
Net Profit0.291.892.02
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share0.090.590.63
Book Value------
Equity32.0032.0032.00
Reserves------
Face Value10.0010.0010.00
Source : Dion Global Solutions Limited

Set email alert for

Action in Socrus Bio Sciences
Micromax, Karbonn or someone else: Who will be India's enduring smartphone brand?
Vajpayee, Advani, Modi: Every leader has given Hindutva a twist "Vajpayee, Advani, Modi: Every leader has given Hindutva a twist"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

Jun 17 2013, 22:16

Subbarao has hit the nail on its head, says Ambit`s Wadhwa

- in MARKET OUTLOOK

Jun 17 2013, 22:17

Pullback on Nifty may continue till 5880: Hemant Thukral

- in MARKET OUTLOOK